CollPlant Biotechnologies logo

CollPlant Biotechnologies (CLGN) Q4 2025 Earnings

CLGN·Reported March 26, 2026·Before market open

CollPlant Biotechnologies reported Q4 2025 revenue of $60.0K (-63.4% YoY), missed analyst consensus of $2.1M by $2.0M. Diluted EPS came in at $-0.67 (-97.1% YoY), missed the $-0.30 consensus by $0.37.

Revenue
$60.0Kmissed by $2.0M
Consensus: $2.1M
Diluted EPS
$-0.67missed by $0.37
Consensus: $-0.30
SEC

SEC Filings

Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet

Filings will appear here once submitted to SEC EDGAR.

Q4 2025 Earnings FAQ

Common questions about CollPlant Biotechnologies's Q4 2025 earnings report.

CollPlant Biotechnologies (CLGN) reported Q4 2025 earnings on March 26, 2026 before market open.

CollPlant Biotechnologies reported revenue of $60.0K and diluted EPS of $-0.67 for Q4 2025.

Revenue missed the consensus estimate of $2.1M by $2.0M. EPS missed the consensus estimate of $-0.30 by $0.37.

Compared to the same quarter a year prior, revenue declined 63.4% from $164.0K a year earlier and diluted EPS declined 97.1% from $-0.34.